Foreign journals publish Amosartan

Hanmi’s anti-hypertension fixed-dose combination, Amosartan (amolodipine + Losartan), was published in international peer-reviewed journals, such as BMC (BioMed Central Research Notes) and AJCD (American Journal of Cardiovascular Drugs).

According to the results of Phase II study of 320 hypertensive patients, featured in January issue of AJCD, combination amlodipine camsylate/losartan (5 mg/...